MSC-4106,99.82%

产品编号:Bellancom-147208| CAS NO:2738542-58-8| 分子式:C18H12F3N3O2| 分子量:359.30

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-147208
3000.00 杭州 北京(现货)
Bellancom-147208
4800.00 杭州 北京(现货)
Bellancom-147208
9500.00 杭州 北京(现货)
Bellancom-147208
14500.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

MSC-4106

产品介绍 MSC-4106 是一种具有口服活性的 YAP/TAZ-TEAD 抑制剂。 MSC-4106 阻断 TEAD1 和 TEAD3 的 auto-palmitoylation,对 NCI-H226 异种移植瘤模型具有抑制作用。
生物活性

MSC-4106 is an orally active and potent inhibitor of YAP/TAZ-TEAD. MSC-4106 inhibits TEAD1 or TEAD3 auto-palmitoylation and shows inhibitory effect on NCI-H226 tumor xenograft model.

体外研究

MSC-4106 (10 μM, 24 h) inhibited SK-HEP-1 reporter and NCI-266 cell viability with IC50 values of 4 nM and 14 nM, respectively.
MSC-4106 (10 μM, 6 h) crystallizes in the P-site of TEAD1, and against TEAD1 or TEAD3 palmitoylation in TEAD-Overexpressing HEK293 Cells by 97.3% and 75.9%, respectively.
MSC-4106 (10 μM, 4 d) targets TEAD indicated by a reduction in viability of NCI-H226 cells.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay

Cell Line: NCI-H226 (YAP dependent); SW620 YAP/TAZ KO (Yap-independent) cells
Concentration: 0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM
Incubation Time: 96 hours
Result: Showed inhibitory effect to NCI-H226 and general cytotoxic to SW620 (IC50 >30 μM).

Immunofluorescence

Cell Line: SK-HEP-1
Concentration: 0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM
Incubation Time: 24 hours
Result: Inhibited YAP-TEAD interation.
体内研究
(In Vivo)

MSC-4106 (100 mg/kg/d; p.o.; 7 d) displays anti-tumor effect with controlled tumor volume and good tolerability with stable body weight in mice.
MSC-4106 (1, 5, 100 mg/kg/d; p.o.; 0-72 h) down-regulates Cyr61 (cysteine-rich angiogenic inducer 61) expression, the TEAD-regulated target gene, in tumor lysates at all time points at 100 mg/kg and 24 h at 5 mg/kg.
Pharmacokinetics (PK) profile in different species

Parameter Mouse Rat Dog
Cl (l/h/kg) 0.2 0.7 0.05
PO t1/2 (h) 45 40 3.6
PO AUC (μg•h/mL) 45 10 33
Vss (L/kg) 2 5 0.3
F (%) >90 80 18
Note: PO studies were performed at 10 mg/kg; MSC-4106 was formulated in 20% Kleptose in 50 mM PBS at pH 7.4.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NCI-H226 xenograft model in H2d Rag2 female mice (9-week-old)
Dosage: 5, 100 mg/kg
Administration: Oral gavage; once daily; 32 days
Result: Resulted tumor growth controlled with 5 mg/kg while regressed with 100 mg/kg dosing after 32 treatment days.
体内研究

MSC-4106 (100 mg/kg/d; p.o.; 7 d) displays anti-tumor effect with controlled tumor volume and good tolerability with stable body weight in mice.
MSC-4106 (1, 5, 100 mg/kg/d; p.o.; 0-72 h) down-regulates Cyr61 (cysteine-rich angiogenic inducer 61) expression, the TEAD-regulated target gene, in tumor lysates at all time points at 100 mg/kg and 24 h at 5 mg/kg.
Pharmacokinetics (PK) profile in different species

Parameter Mouse Rat Dog
Cl (l/h/kg) 0.2 0.7 0.05
PO t1/2 (h) 45 40 3.6
PO AUC (μg•h/mL) 45 10 33
Vss (L/kg) 2 5 0.3
F (%) >90 80 18
Note: PO studies were performed at 10 mg/kg; MSC-4106 was formulated in 20% Kleptose in 50 mM PBS at pH 7.4.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NCI-H226 xenograft model in H2d Rag2 female mice (9-week-old)
Dosage: 5, 100 mg/kg
Administration: Oral gavage; once daily; 32 days
Result: Resulted tumor growth controlled with 5 mg/kg while regressed with 100 mg/kg dosing after 32 treatment days.
体内研究

MSC-4106 (100 mg/kg/d; p.o.; 7 d) displays anti-tumor effect with controlled tumor volume and good tolerability with stable body weight in mice.
MSC-4106 (1, 5, 100 mg/kg/d; p.o.; 0-72 h) down-regulates Cyr61 (cysteine-rich angiogenic inducer 61) expression, the TEAD-regulated target gene, in tumor lysates at all time points at 100 mg/kg and 24 h at 5 mg/kg.
Pharmacokinetics (PK) profile in different species

Parameter Mouse Rat Dog
Cl (l/h/kg) 0.2 0.7 0.05
PO t1/2 (h) 45 40 3.6
PO AUC (μg•h/mL) 45 10 33
Vss (L/kg) 2 5 0.3
F (%) >90 80 18
Note: PO studies were performed at 10 mg/kg; MSC-4106 was formulated in 20% Kleptose in 50 mM PBS at pH 7.4.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NCI-H226 xenograft model in H2d Rag2 female mice (9-week-old)
Dosage: 5, 100 mg/kg
Administration: Oral gavage; once daily; 32 days
Result: Resulted tumor growth controlled with 5 mg/kg while regressed with 100 mg/kg dosing after 32 treatment days.
性状Solid
溶解性数据
In Vitro: 

DMSO : 250 mg/mL (695.80 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.7832 mL 13.9159 mL 27.8319 mL
5 mM 0.5566 mL 2.7832 mL 5.5664 mL
10 mM 0.2783 mL 1.3916 mL 2.7832 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服